Psychiatry tariff cap: What remains open before the decision
A limit of 1,577 tax points is planned for 2027. The Federal Council must still approve the concept. Whether and how it affects psychiatric practices is unresolved.

A tariff cap can be the same everywhere and still affect medical specialties very differently. That is exactly what the dispute over the new upper limit in the outpatient medical tariff is about: the tariff partners' concept for 2027 foresees a monthly average of 1,577 tariff points of medical services per working day. A blanket exemption for psychiatry and psychotherapy is not planned. The Federal Council has yet to decide on the application submitted on 2 June 2026; according to the FOPH, the decision is expected in the fourth quarter of 2026.
The statutory mandate is settled, but the concrete implementation is still subject to the approval procedure. The concept concerns the medical component of Tardoc. The limit is meant to prevent unrealistically high volumes of services from being billed to compulsory health insurance. What is reviewed is not each individual day in isolation, but the monthly average under the personal GLN number of the treating physician.
Why the mix of services is decisive
In many specialties, high costs arise from equipment, materials or clearly delimited procedures. Psychiatric treatment, by contrast, consists essentially of medical time: consultations, crisis interventions, assessments, documentation and coordination with relatives, clinics or social services. That alone does not mean psychiatric practices reach the limit more often than other specialties. What matters is which tariff items are actually billed.
That does not automatically mean care will fall away. The monthly average smooths out intensive individual days. According to the FOPH, infrastructure and staff services, outpatient flat rates, emergency and urgency supplements in private practice, as well as reports and expert opinions are not counted. What matters is which services are counted and how the review is carried out in practice.

What is documented — and what is still missing
The FMH expects that most physicians will not reach the limit. It analyses billing data in order to identify particularly affected specialties and practice situations. The information linked here contains no regionally broken-down impact assessment for psychiatry. According to the FMH, the consequences of exceeding the limit are also not yet defined.
Both strong claims therefore remain unproven: it is not established that the limit will inevitably trigger a nationwide reduction in care, nor that it will leave psychiatric care without consequences. The Medinside specialist report documents the concern of service providers, while payers and tariff partners point to a uniform limit and abuse control.
For a serious assessment, at least four indicators are needed after the start: the number of affected GLN numbers, the volume of reduced services, the development of waiting times and regional shifts between practice and clinic. Without this data, a tariff question quickly turns into a political battle of beliefs.
The incentive can take effect before any reduction
Rules change behaviour not only when an invoice is rejected. Practices could distribute long appointments differently, accept fewer time-intensive patients or refer more patients to clinics. Such reactions would be rational, but they could have undesirable consequences — especially for people in acute crises or with complex multiple diagnoses.
Conversely, review is justified. Even time-based tariffs need plausibility limits. Otherwise premium payers pay for services that arithmetically do not fit into a working day. The question is therefore not 'review or no review', but whether the same indicator reflects medically comparable workloads across different specialties.
A tariff needs feedback to care delivery
The forthcoming approval is therefore more than a formality. Until then, exemption provisions and calculation should be transparent enough for practices to plan.
For patients, what counts is not the number 1,577 but access to treatment. Good regulation therefore links invoice review with care monitoring. If the data after introduction show longer waiting times, earlier dropouts or a shift into more expensive inpatient services, adjustments must follow. If such effects fail to materialise, that would also be an important result. Both can only be assessed with published data.
A tax point is not simply a minute
The limit should not be read as a rigid number of treatable minutes. Tariff items weight different medical activities differently; there are also rules on absence services and coordination. In addition, the monthly average is calculated on the basis of recognised working days. Whether a practice reaches the limit therefore depends on its mix of services. It is precisely this complexity that argues for an analysis of real billing data rather than blanket assumptions about typical working days.



